{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:11:54Z","timestamp":1776503514224,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bbrc.2016.05.066","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T22:27:18Z","timestamp":1463178438000},"page":"169-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2"],"prefix":"10.1016","volume":"475","author":[{"given":"Xuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbrc.2016.05.066_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics","volume":"65","author":"Torre","year":"2012","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bbrc.2016.05.066_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.clinthera.2016.02.007","article-title":"Beyond chemotherapy: an overview and review of targeted therapy in cervical cancer","volume":"38","author":"Crafton","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bbrc.2016.05.066_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010260.pub2","article-title":"Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer","volume":"4","author":"Kokka","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.bbrc.2016.05.066_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2014.01.042","article-title":"A\u00a0systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer","volume":"133","author":"Lorusso","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2016.05.066_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajog.2015.07.022","article-title":"Changing paradigms in the systemic treatment of advanced cervical cancer","volume":"214","author":"Pfaendler","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.bbrc.2016.05.066_bib6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bbrc.2016.05.066_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/bjc.2015.253","article-title":"MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients","volume":"113","author":"Pichler","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbrc.2016.05.066_bib8","first-page":"1504","article-title":"Aberrant expression profile of translationally controlled tumor protein and tumor-suppressive microRNAs in cervical cancer","volume":"20","author":"Hou","year":"2015","journal-title":"J.\u00a0BUON"},{"issue":"5","key":"10.1016\/j.bbrc.2016.05.066_bib9","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3892\/or.2016.4651","article-title":"Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"51","key":"10.1016\/j.bbrc.2016.05.066_bib10","doi-asserted-by":"crossref","first-page":"30342","DOI":"10.1074\/jbc.M115.691857","article-title":"miR-346 up-regulates argonaute 2 (AGO2) protein expression to augment the activity of other MicroRNAs (miRNAs) and contributes to cervical cancer cell malignancy","volume":"290","author":"Guo","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2016.05.066_bib11","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.18632\/oncotarget.3088","article-title":"Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bbrc.2016.05.066_bib12","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.3892\/mmr.2015.4390","article-title":"MicroRNA-328 directly targets p21-activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivity","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2016.05.066_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2016.01.020","article-title":"MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1","volume":"470","author":"Han","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbrc.2016.05.066_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/neuonc\/not164","article-title":"MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation","volume":"16","author":"Delic","year":"2014","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.1016\/j.bbrc.2016.05.066_bib15","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.25939","article-title":"MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration","volume":"129","author":"Arora","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbrc.2016.05.066_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbrc.2015.02.138","article-title":"MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer","volume":"459","author":"Wang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bbrc.2016.05.066_bib17","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00404-015-3713-2","article-title":"miR-31 functions as an oncogene in cervical cancer","volume":"292","author":"Zheng","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"issue":"10","key":"10.1016\/j.bbrc.2016.05.066_bib18","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1007\/s13277-015-3483-2","article-title":"MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7","volume":"36","author":"Deng","year":"2015","journal-title":"Tumour Biol."},{"issue":"17","key":"10.1016\/j.bbrc.2016.05.066_bib19","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1016\/j.febslet.2014.07.020","article-title":"miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer","volume":"588","author":"Li","year":"2014","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.bbrc.2016.05.066_bib20","first-page":"676","article-title":"The inhibitory role of miR-214 in cervical cancer cells through directly targeting mitochondrial transcription factor A (TFAM)","volume":"35","author":"Wen","year":"2014","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.bbrc.2016.05.066_bib21","first-page":"3159","article-title":"MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma","volume":"8","author":"Luo","year":"2015","journal-title":"Onco Targets Ther."},{"issue":"24","key":"10.1016\/j.bbrc.2016.05.066_bib22","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1158\/1078-0432.CCR-13-2500","article-title":"Molecular pathways: microRNAs, cancer cells, and microenvironment. Berindan-Neagoe I","volume":"20","author":"Calin","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"2 Pt A","key":"10.1016\/j.bbrc.2016.05.066_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.canlet.2014.10.011","article-title":"The emerging roles of microRNAs in cancer metabolism","volume":"356","author":"Chan","year":"2015","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbrc.2016.05.066_bib24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.7314\/APJCP.2015.16.4.1575","article-title":"MicroRNA-328 inhibits proliferation of human melanoma cells by targeting TGF\u03b22","volume":"16","author":"Li","year":"2015","journal-title":"Asian Pac J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.bbrc.2016.05.066_bib25","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1124\/mol.108.054163","article-title":"MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP\/ABCG2) in human cancer cells","volume":"75","author":"Pan","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbrc.2016.05.066_bib26","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1523\/JNEUROSCI.4787-14.2015","article-title":"The Wnt effector transcription factor 7-like 2 positively regulates oligodendrocyte differentiation in a manner independent of Wnt\/\u03b2-catenin signaling","volume":"35","author":"Hammond","year":"2015","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.bbrc.2016.05.066_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3892\/or.2013.2831","article-title":"miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT\/TCF-4 pathway","volume":"31","author":"Gu","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2016.05.066_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/carcin\/bgm267","article-title":"Downregulation of Dkk3 activates beta-catenin\/TCF-4 signaling in lung cancer","volume":"29","author":"Yue","year":"2008","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.bbrc.2016.05.066_bib29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bcp.2014.03.006","article-title":"DIF-1 inhibits tumor growth in\u00a0vivo reducing phosphorylation of GSK-3\u03b2 and expressions of cyclin D1 and TCF7L2 in cancer model mice","volume":"89","author":"Takahashi-Yanaga","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbrc.2016.05.066_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","article-title":"The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells","volume":"111","author":"van de Wetering","year":"2002","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbrc.2016.05.066_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00784-015-1536-y","article-title":"Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression","volume":"20","author":"Lin","year":"2016","journal-title":"Clin. Oral Investig."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16307586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16307586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T17:10:20Z","timestamp":1567876220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16307586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0006291X16307586"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.05.066","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"microRNA-328 inhibits cervical cancer cell proliferation and tumorigenesis by targeting TCF7L2","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.05.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}